Adenovirus-mediated gene therapy of ovarian cancer in a mouse model

American Journal of Obstetrics and Gynecology

Volumn 175, Issue 5, 1996, Pages 1260-1265

  Behbakht, K ^a   Benjamin, I ^a   Chiu, H C ^a   Eck, S L ^a   Van Deerlin, P G ^a   Rubin, S C ^a   Boyd, J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adenovirus; ganciclovir; Gene theraphy; mouse; ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; GENE THERAPY; GROWTH INHIBITION; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; REPORTER GENE; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS RECOMBINANT;

EID: 0029962622     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70038-8     Document Type: Article

References (26)

1. BA Miller LAG Ries BF Hankey CL Kosary A Harras SS Devesa SEER Cancer Statistics Review: 1973-1990 1993 National Cancer Institute Bethesda
2. RF Ozols SC Rubin AJ Dembo SJ. Robboy WJ Hoskins CA Perez RC Young Principles and practice of gynecologic oncology. 1992 Lippincott Philadelphia 731 782
3. WR Smythe HC Hwang AA Elshami KM Amin SL Eck BL Davidson Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene Ann Surg 222 1995 78 86
4. C Qian R Bilbao O Bruna J. Prieto Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase Hepatology 22 1995 118 123
5. MJ Perez-Cruet TW Trask SH Chen JC Goodman SL Woo RG Grossman Adenovirus-mediated gene therapy of experimental gliomas J Neurosci Res 39 1994 506 511
6. WR Smythe HC Hwang KM Amin SL Eck BL Davidson JM Wilson Use of a recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system Cancer Res 54 1994 2055 2059
7. T Liu W Zhang DL Taylor JA Roth H Goepfert GL. Clayman Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus Cancer Res 54 1994 3662 3667
8. WR Smythe LR Kaiser HC Hwang KM Amin JM Pilewski SJ Eck Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma Ann Thorac Surg 57 1994 1395 1401
9. MH St. Clair CU Lambe PA. Furman Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information Antimicrob Agents Chemother 31 1987 844 849
10. WR Smythe HC Hwang AA Elshami KM Amin SM Albelda LR. Kaiser Differential sensitivity of thoracic malignant tumors to adenovirus-mediated drug sensitization gene therapy J Thorac Cardiovasc Surg 109 1995 626 631
11. BW O'Malley S-H Chen MR Schwartz SL. Woo Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model Cancer Res 55 1995 1080 1085
12. T Osaki Y Tanio I Tachibana S Hosie T Kumagai I Kowase Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene Cancer Res 54 1994 5258 5261
13. Y Manome M Abe M Hagen HA Fine DW. Kufe Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir Cancer Res 54 1994 5408 5413
14. RJ Cristiano LC Smith SL. Woo Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes Proc Natl Acad Sci U S A 90 1993 2122 2126
15. KR Geisinger TE Kute MJ Pettenati CE Welander Y Dennard LA Collins Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors Cancer 63 1989 280 289
16. JA Boyd GP Siegal DG. Kaufman Establishment and characterization of a human cell line from a serous papillary endometrial carcinoma Gynecol Oncol 33 1989 301 312
17. JR Forsayeth PD. Garcia Adenovirus-mediated transfection of cultured cells BioTechniques 17 1994 354 359
18. R Vile SJ. Russel Gene transfer technologies for the gene therapy of cancer Gene Ther 1 1994 88 98
19. SM Freeman CN Abboud KA Whartenby CH Packman DS Koeplin FL Moolten The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 53 1993 5274 5283
20. WL Bi LM Parysek R Warnick PJ. Stambrook In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy Hum Gene Ther 4 1993 725 731
21. L Philipson K Longberg-Holm U. Pettersson Virus-receptor interaction in an adenovirus system J Virol 2 1968 1064 1075
22. TJ Wickham EJ Filardo DA Cheresh GR. Nemerow Integrin αvβ5 selectively promotes adenovirus mediated cell membrane permeabilization J Cell Biol 127 1994 257 264
23. ME Rosenfeld M Feng SI Michael GP Siegal RD Alvarez DT. Curiel Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir Clin Cancer Res 1 1995 1571 1580
24. RL Dedrick CE Myers PM Bungay VT DeVita Jr. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer Cancer Treat Rep 62 1978 1 11
25. M. Markman Intraperitoneal chemotherapy Semin Oncol 18 1991 248 254
26. AA Elshami JC Kucharczuk DH Sterman WR Smythe HC Hwang KM Amin The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene Ann Surg 222 1995 307 310